ArticleJournal of blood medicine2022

Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.

Jamile Shammo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.